CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 170 enrolled
Drug / intervention
Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00629265
NCT00629265N/ACompleted

Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients

Boston Medical Center·interventional·Posted Mar 5, 2008·Updated Oct 31, 2014

In Brief

A clinical study evaluating Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES) for Dysphagia. Completed, enrolled 170 participants across 14 sites.

Detailed Summary

The purpose of the investigation is to learn whether intense swallowing exercise or intense swallowing exercise coupled with electrical stimulation (E-Stim) helps patients who had head/neck cancer and currently have dysphagia swallow better.

Study Details

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 5, 2008
Enrollment StartMar 1, 2008
Primary CompletionApr 1, 2012
Study CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 18.3 years ago

Interventions

Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES)device

NMES or Sham NMES will be paired with repeated, effortful swallowing behavior, for 60 swallows, 2 times a day, 6 days a week, for 12 weeks.